Taisei Mushiroda

ムシロダタイセイ | Taisei Mushiroda

Affiliation and department：
Job title：チームリーダー
Papers (92)：

Duan Liu, Balmiki Ray, Drew R. Neavin, Jiabin Zhang, Arjun P. Athreya, Joanna M. Biernacka, William V. Bobo, Daniel K. Hall-Flavin, Michelle K. Skime, Hongjie Zhu, et al. Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: Metabolomics-informed genomics. Translational Psychiatry. 2018. 8. 1. 10
Taylor JC, Bongartz T, Massey J, Mifsud B, Spiliopoulou A, Scott IC, Wang J, Morgan M, Plant D, Colombo M, et al. Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients. The pharmacogenomics journal. 2018. 18. 4. 528-538
Yoshihama T, Fukunaga K, Hirasawa A, Nomura H, Akahane T, Kataoka F, Yamagami W, Aoki D, Mushiroda T. GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes. Oncotarget. 2018. 9. 51. 29789-29800
Taisei Mushiroda, Yukitoshi Takahashi, Teiichi Onuma, Yoshiaki Yamamoto, Tetsumasa Kamei, Tohru Hoshida, Katsuya Takeuchi, Kotaro Otsuka, Mitsutoshi Okazaki, Masako Watanabe, et al. Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population. JAMA neurology. 2018. 75. 7. 842-849
Hideyuki Ujiie, Ken Muramatsu, Taisei Mushiroda, Takeshi Ozeki, Hideaki Miyoshi, Hiroaki Iwata, Akinobu Nakamura, Hiroshi Nomoto, Kyu Yong Cho, Norihiro Sato, et al. HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors. The Journal of investigative dermatology. 2018. 138. 5. 1201-1204

ｍore...

Patents (3)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page